Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 3/2011

01-06-2011 | Correspondence

Measuring mortality in Staphylococcus aureus bloodstream infections: are 3 months of follow-up enough?

Authors: A. J. Kaasch, S. Rieg, S. Neumann, H. Seifert, W. V. Kern

Published in: Infection | Issue 3/2011

Login to get access

Excerpt

Hanses et al. [1] recently published data from a retrospective study of patients with Staphylococcus aureus bacteremia (SAB). The authors observed a considerable additional mortality due to SAB beyond 90 days and concluded that long-term survival data should be taken into account in outcome studies involving patients with SAB. …
Literature
1.
Hanses F, Spaeth C, Ehrenstein BP, Linde HJ, Scholmerich J, Salzberger B. Risk factors associated with long-term prognosis of patients with Staphylococcus aureus bacteremia. Infection. 2010;39:465–70.
2.
Seifert H, Wisplinghoff H, Kaasch A, Achilles K, Langhorst A, Peyerl-Hoffmann G, et al. Epidemiologie, Verlauf und Prognose der Staphylococcus aureus Bakteriämie—Erste Ergebnisse der INSTINCT Kohorte. Dtsch Med Wochenschr. 2008;133:340–5.PubMedCrossRef
3.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.PubMedCrossRef
4.
Chang FY, Peacock JE Jr, Musher DM, Triplett P, MacDonald BB, Mylotte JM, et al. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore). 2003;82:333–9.CrossRef
Metadata
Title
Measuring mortality in Staphylococcus aureus bloodstream infections: are 3 months of follow-up enough?
Authors
A. J. Kaasch
S. Rieg
S. Neumann
H. Seifert
W. V. Kern
Publication date
01-06-2011
Publisher
Springer-Verlag
Published in
Infection / Issue 3/2011
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-011-0104-x

Other articles of this Issue 3/2011

Infection 3/2011 Go to the issue

Review

Costs of hospital-acquired infection and transferability of the estimates: a systematic review

Clinical and Epidemiological Study

Significance of herpesvirus 6 in BAL fluid of hematology patients with acute respiratory failure

Correspondence

Glycopeptide and daptomycin resistance in community-associated MRSA in the UK

Case Report

Breast abscess due to Actinomyces europaeus

Correspondence

Unusual presentation of Streptococcus pneumoniae-induced septic shock 36 years after splenectomy

Case Report

Fatal Pseudomonas aeruginosa pneumonia in a previously healthy woman was most likely associated with a contaminated hot tub
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits